| scholarly article | Q13442814 |
| P50 | author | Alexander M Ishov | Q61105836 |
| Angelie Rivera-Rodriguez | Q61105854 | ||
| Carlos Rinaldi | Q88145581 | ||
| P2093 | author name string | Viacheslav M Morozov | |
| Andreina Chiu-Lam | |||
| P2860 | cites work | Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint | Q24648791 |
| Treatment of carcinomatosis using cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in adolescents and young adults | Q50438356 | ||
| Clinical applications of magnetic nanoparticles for hyperthermia. | Q52917224 | ||
| Efficacy and safety of docetaxel (Taxotere) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experience | Q73446651 | ||
| Arrest in metaphase and anatomy of mitotic catastrophe: mild heat shock in two human osteosarcoma cell lines | Q73692745 | ||
| Cells enter a unique intermediate 4N stage, not 4N-G1, after aborted mitosis | Q80595690 | ||
| Androgen receptor on the move: boarding the microtubule expressway to the nucleus | Q26862560 | ||
| Microtubule-binding agents: a dynamic field of cancer therapeutics | Q27690249 | ||
| The spindle-assembly checkpoint in space and time | Q27860766 | ||
| Microtubules as a target for anticancer drugs | Q28253993 | ||
| Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. | Q30465367 | ||
| Heating the patient: a promising approach? | Q33184112 | ||
| Colloidal dispersions of monodisperse magnetite nanoparticles modified with poly(ethylene glycol). | Q33377807 | ||
| Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance | Q33382292 | ||
| How Taxol/paclitaxel kills cancer cells. | Q34166802 | ||
| If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells | Q34625589 | ||
| Taxanes, microtubules and chemoresistant breast cancer. | Q34722919 | ||
| Docetaxel and paclitaxel in the treatment of breast cancer: a review of clinical experience | Q35783180 | ||
| Optimization of synthesis and peptization steps to obtain iron oxide nanoparticles with high energy dissipation rates | Q35933164 | ||
| Death through a tragedy: mitotic catastrophe | Q37135368 | ||
| Focused RF hyperthermia using magnetic fluids. | Q37330373 | ||
| Magnetic fluid hyperthermia enhances cytotoxicity of bortezomib in sensitive and resistant cancer cell lines | Q37414942 | ||
| Mitosis as an anti-cancer target | Q37845641 | ||
| Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles | Q37878121 | ||
| Survival benefit of adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the different time-points of treatment of ovarian cancer: review of evidence | Q38010511 | ||
| Current status and future directions of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer | Q38047549 | ||
| Thermal potentiation of chemotherapy by magnetic nanoparticles | Q38145565 | ||
| Magnetic fluid hyperthermia: advances, challenges, and opportunity. | Q38150882 | ||
| Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise | Q38171356 | ||
| Enhanced proteotoxic stress: one of the contributors for hyperthermic potentiation of the proteasome inhibitor bortezomib using magnetic nanoparticles | Q38848670 | ||
| Combining magnetic particle imaging and magnetic fluid hyperthermia in a theranostic platform | Q39054379 | ||
| Lysosomal membrane permeabilization by targeted magnetic nanoparticles in alternating magnetic fields | Q39147847 | ||
| Monitoring APC/C activity in the presence of chromosomal misalignment in unperturbed cell populations | Q39418229 | ||
| EGFR-targeted magnetic nanoparticle heaters kill cancer cells without a perceptible temperature rise. | Q39491158 | ||
| Intracellular heating of living cells through Néel relaxation of magnetic nanoparticles | Q40104377 | ||
| Daxx shortens mitotic arrest caused by paclitaxel | Q40138923 | ||
| Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme | Q42060733 | ||
| Targeting mitotic exit with hyperthermia or APC/C inhibition to increase paclitaxel efficacy | Q42790803 | ||
| Thermal Decomposition Synthesis of Iron Oxide Nanoparticles with Diminished Magnetic Dead Layer by Controlled Addition of Oxygen | Q46421023 | ||
| Hyperthermia induced by magnetic nanoparticles improves the effectiveness of the anticancer drug cis-diamminedichloroplatinum | Q46490856 | ||
| Theoretical Predictions for Spatially-Focused Heating of Magnetic Nanoparticles Guided by Magnetic Particle Imaging Field Gradients | Q46508376 | ||
| Effect of poly(ethylene oxide)-silane graft molecular weight on the colloidal properties of iron oxide nanoparticles for biomedical applications | Q47315060 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biophysics | Q7100 |
| nanoparticle | Q61231 | ||
| paclitaxel | Q423762 | ||
| bioengineering | Q580689 | ||
| drug discovery | Q1418791 | ||
| magnetite nanoparticle | Q3870166 | ||
| magnetic nanoparticle | Q117817683 | ||
| P304 | page(s) | 4771-4779 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | International Journal of Nanomedicine | Q6051502 |
| P1476 | title | Magnetic nanoparticle hyperthermia potentiates paclitaxel activity in sensitive and resistant breast cancer cells | |
| P478 | volume | 13 |
| Q90344538 | Superparamagnetic iron oxide nanoparticles drive miR-485-5p inhibition in glioma stem cells by silencing Tie1 expression | cites work | P2860 |
Search more.